Fred Ledon

Statistics

Publications

Citations

150

H-Index

Active since

2011

Affiliations

Avanir Pharmaceuticals (United States)(Current)

Indiana University School of Medicine

Meridien Research

University of California, Los Angeles

Indiana University – Purdue University Indianapolis

Fred Ledon is an author at Avanir Pharmaceuticals (United States) specializing in neurology, dementia pharmacotherapy, and multiple sclerosis pharmacotherapy.

Publications per year

2011–2018

Publications

Eyelash growth in subjects treated with bimatoprost: A multicenter, randomized, double-masked, vehicle-controlled, parallel-group study

Stacy Smith, Steven Fagien, Scott M. Whitcup et al. · Journal of the American Academy of Dermatology · 2011 · 79 citations

Veterinary Medicine, Ophthalmology, Eyelid Disorders +6

PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury

Flora M. Hammond, David N. Alexander, Andrew J. Cutler et al. · BMC Neurology · 2016 · 36 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect Among Study Participants With Traumatic Brain Injury: Results From the PRISM‐II Open Label Study

Flora M. Hammond, William Sauvé, Fred Ledon et al. · PM&R · 2018 · 22 citations · Full text

Medicine, Neurology, Pharmacology +14

An open-label study to assess safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in dementia: PRISM II results

Rachelle S. Doody, Stephen D’Amico, Andrew J. Cutler et al. · CNS Spectrums · 2015 · 13 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

1–4 of 4